The US Food and Drug Administration (FDA) has approved Fujirebio Diagnostics’ Alzheimer’s disease (AD) blood test to help ...

The Global Alzheimer’s Platform Foundation® (GAP) applauds the FDA's clearance of the first blood test to diagnose ...

The Lumipulse blood test identifies the presence of amyloid plaques, a hallmark of Alzheimer’s disease that impairs normal brain function.

Since Alzheimer's disease affects over 7 million people in the U.S., potentially doubling to 14 million by 2050, earlier ...

The very first blood test for Alzheimer's disease detection has been green-lit by the US Food and Drug Administration (FDA), ...

Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s ...

Experts say the test could dramatically improve access to earlier, more accurate diagnoses, particularly for older Americans ...

The FDA has approved the first blood test to detect early Alzheimer’s replacing invasive scans Learn how this game-changing tool could transform diagnosis and treatment ...

Mirage.News real-time media portal. We acknowledge the traditional owners of country throughout Australia. All timestamps on this site are AEST/AEDT and all times in the articles are local times ...